GelSana Therapeutics, Inc.

Amendment

CIK: 0002002665·Biotechnology·DELAWARE·Filed: Mar 6, 2026

Total Offering

$3,681,738

Amount Sold

$3,481,740

Investors

20

First Sale

Nov 20, 2023

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Melissa Krebs	Related Person
Mike Freeman	Related Person
Diana Verrilli	Related Person

Company

GelSana Therapeutics, Inc.

12635 E MONTVIEW BLVD STE 216

AURORA, CO, 80045

(216) 502-0901

SEC Filing

0002002665-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.